跳至主要内容
临床试验/JPRN-UMIN000031519
JPRN-UMIN000031519已完成未知

Clinical evaluation of the efficacy and safety of Hochuekkito for fatigue in patients with myeloproliferative neoplasms - Hochuekkito for myeloproliferative neoplasms related fatigue

Department of Hematology, Juntendo University School of Medicine0 个研究点目标入组 110 人开始时间: 2018年4月1日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
110

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1.Severe complications including liver disease and respiratory disease 2.Alergy to chinese traditional medicine 3.Treated with other chinese traditional medicine within 2 weeks. 4.Participated to other clinical trials 5.Determined as inappropriate by the researcher

研究者

发起方
Department of Hematology, Juntendo University School of Medicine

相似试验